Leadership Changes - Iridex Corporation appointed Patrick Mercer as the new Chief Executive Officer and President effective October 1, 2024, succeeding David Bruce [1] - Scott Shuda was appointed as Executive Chairman of the board of directors, having previously served as Chairman [1] Strategic Review Process - The board believes that the leadership change could accelerate progress towards a transaction under the strategic review process initiated last year [2] - The company is currently engaged in discussions with multiple entities regarding potential transactions [2] Company Overview - Iridex is a leader in developing and marketing laser-based medical systems for ophthalmology, focusing on treatments for glaucoma and retinal diseases [4] - The company's proprietary MicroPulse® technology offers safe and effective treatments for sight-threatening eye conditions [4] - Iridex products are distributed in over 100 countries, with a direct sales force in the United States and independent distributors internationally [4]
Iridex Appoints Patrick Mercer as Chief Executive Officer